|
1
|
Global Burden of Disease Cancer
Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L,
Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al:
Global, regional, and national cancer incidence, mortality, years
of life lost, years lived with disability, and disability-adjusted
life-years for 32 cancer groups, 1990 to 2015: A systematic
analysis for the global burden of disease study. JAMA Oncol.
3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ke XS, Liu CM, Liu DP and Liang CC:
MicroRNAs: Key participants in gene regulatory networks. Curr Opin
Chem Biol. 7:516–523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan Y, Zhang J, Fu H and Shen L: miR-144
functions as a tumor suppressor in breast cancer through inhibiting
ZEB1/2-mediated epithelial mesenchymal transition process. Onco
Targets Ther. 9:6247–6255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zha W, Cao L, Shen Y and Huang M: Roles of
Mir-144-ZFX pathway in growth regulation of non-small-cell lung
cancer. PLoS One. 8:e741752013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao M, Huang J, Gui K, Xiong M, Cai G, Xu
J, Wang K, Liu D, Zhang X and Yin W: The downregulation of miR-144
is associated with the growth and invasion of osteosarcoma cells
through the regulation of TAGLN expression. Int J Mol Med.
34:1565–1572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou S, Ye W, Zhang Y, Yu D, Shao Q, Liang
J and Zhang M: miR-144 reverses chemoresistance of hepatocellular
carcinoma cell lines by targeting Nrf2-dependent antioxidant
pathway. Am J Transl Res. 8:2992–3002. 2016.PubMed/NCBI
|
|
12
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sureban SM, May R, Mondalek FG, Qu D,
Ponnurangam S, Pantazis P, Anant S, Ramanujam RP and Houchen CW:
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144
and inhibits colorectal cancer tumor growth via a Notch-1 dependent
mechanism. J Nanobiotechnology. 9:402011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akiyoshi S, Fukagawa T, Ueo H, Ishibashi
M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K and Mori M:
Clinical significance of miR-144-ZFX axis in disseminated tumour
cells in bone marrow in gastric cancer cases. Br J Cancer.
107:13452012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Xue H, Zhang J, Suo T, Xiang Y,
Zhang W, Ma J, Cai D and Gu X: MicroRNA-144 inhibits the metastasis
of gastric cancer by targeting MET expression. J Exp Clin Cancer
Res. 34:352015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET,
Aprelikova O, Choi IJ, Munroe DJ and Green JE: miRNA signature
associated with outcome of gastric cancer patients following
chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu YF, Lüscher B, Admon A, Mermod N and
Tjian R: Transcription factor AP4 contains multiple dimerization
domains that regulate dimer specificity. Genes Dev. 4:1741–1752.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edmondson DG and Olson EN: A gene with
homology to the myc similarity region of MyoD1 is expressed during
myogenesis and is sufficient to activate the muscle differentiation
program. Genes Dev. 3:628–640. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murre C, McCaw PS and Baltimore D: A new
DNA binding and dimerization motif in immunoglobulin enhancer
binding, daughterless, MyoD, and myc proteins. Cell. 56:777–783.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jung P and Hermeking H: The c-MYC-AP4-p21
cascade. Cell Cycle. 8:982–989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsujimoto K, Ono T, Sato M, Nishida T,
Oguma T and Tadakuma T: Regulation of the expression of caspase-9
by the transcription factor activator protein-4 in
glucocorticoid-induced apoptosis. J Biol Chem. 280:27638–27644.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim MY, Jeong BC, Lee JH, Kee HJ, Kook H,
Kim NS, Kim YH, Kim JK, Ahn KY and Kim KK: A repressor complex, AP4
transcription factor and geminin, negatively regulates expression
of target genes in nonneuronal cells. Proc Natl Acad Sci USA.
103:13074–13079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao J, Tang M, Li WL, Xie J, Du H, Tang
WB, Wang H, Chen XW, Xiao H and Li Y: Upregulation of activator
protein-4 in human colorectal cancer with metastasis. Int J Surg
Pathol. 17:16–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin T, et al: Identification of
Transcription Factor AP4 as the Regulator that Upregulates the
Expression of L-plastin in Hormone-Independent Prostate Cancer. J
Sun Yat-Sen Univ (Med Sci). 19–23. 2006.
|
|
29
|
Buechler S: Low expression of a few genes
indicates good prognosis in estrogen receptor positive breast
cancer. BMC Cancer. 9:2432009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xinghua L, Bo Z, Yan G, Lei W, Changyao W,
Qi L, Lin Y, Kaixiong T, Guobin W and Jianying C: The
overexpression of AP4 as a prognostic indicator for gastric
carcinoma. Med Oncol. 29:871–877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung P, Menssen A, Mayr D and Hermeking H:
AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci
USA. 105:15046–15051. 2008. View Article : Google Scholar : PubMed/NCBI
|
